HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ott, G. Y. Articles by Cobanoglu, A. Search for Related Content PubMed PubMed Citation Articles by Ott, G. Y. Articles by Cobanoglu, A.

The Annals of Thoracic Surgery, Vol 57, 76-81, Copyright © 1994 by The Society of Thoracic Surgeons

ARTICLES

Cardiac allografts from high-risk donors: excellent clinical results

GY Ott, RE Herschberger, RR Ratkovec, D Norman, JD Hosenpud and A Cobanoglu
Oregon Cardiac Transplant Program, Oregon Health Sciences University, Portland 97201-3098.

Rising waiting list mortality and increasing demand for donor organs have led to extension of traditionally accepted criteria for evaluation of cardiac grafts. From December 1985 to June 1992, 188 cardiac grafts were orthotopically transplanted into 178 recipients. Of these grafts, 38.3% (72/188) were defined as high-risk donors. Risk criteria included prolonged cardiopulmonary resuscitation, age greater than 40 years, high inotrope requirements, undersizing by more than 20% body weight, significant wall motion impairment by echocardiography, elevation of myocardial enzyme levels, and cold ischemia time greater than 4 hours. There were no recipient deaths attributable to primary graft failure in the perioperative period. Operative (30-day), 1-year and 5-year survival was 95.5%, 86.1%, and 77.3%, respectively, in the high-risk group compared with 93.7%, 86.0%, and 67.2%, respectively, in the low- risk donor cohort (p = 0.94). Comparison of duration of postoperative inotrope use, intensive care unit stay, total hospital stay, and in- hospital costs revealed no significant trends favoring either group in postoperative morbidity. Among long-term survivors, development of graft coronary disease was noted in 47.1% (24/51) of the high-risk donor group and only 17.4% (12/69) of the remaining group (p = 0.0005). Left ventricular ejection fractions in the high risk donor group were 0.58 +/- 0.01 at 2 years. Review of this series suggests that selective use of apparently compromised cardiac donors is compatible with excellent cardiac function and survival. Higher incidence of graft vasculopathy may cause significant morbidity during late follow-up.

This article has been cited by other articles:

				M. J. Russo, R. R. Davies, R. A. Sorabella, T. P. Martens, I. George, F. H. Cheema, S. Mital, R. S. Mosca, and J. M. Chen Adult-age donors offer acceptable long-term survival to pediatric heart transplant recipients: An analysis of the United Network of Organ Sharing database. J. Thorac. Cardiovasc. Surg., November 1, 2006; 132(5): 1208 - 1212. [Abstract] [Full Text] [PDF]

				D. Gupta, V. Piacentino III, M. Macha, A. K. Singhal, J. P. Gaughan, J. B. McClurken, B. I. Goldman, C. A. Fisher, D. Beltramo, J. Monacchio, et al. Effect of older donor age on risk for mortality after heart transplantation Ann. Thorac. Surg., September 1, 2004; 78(3): 890 - 899. [Abstract] [Full Text] [PDF]

				A. M. Scheule, G. J. Zimmerman, J. K. Johnston, A. J. Razzouk, S. R. Gundry, and L. L. Bailey Duration of Graft Cold Ischemia Does Not Affect Outcomes in Pediatric Heart Transplant Recipients Circulation, September 24, 2002; 106(12_suppl_1): I-163 - I-167. [Abstract] [Full Text] [PDF]

				C. Blanche, D. A. Blanche, B. Kearney, M. Sandhu, L. S. C. Czer, A. Kamlot, A. Hickey, and A. Trento Heart transplantation in patients seventy years of age and older: A comparative analysis of outcome J. Thorac. Cardiovasc. Surg., March 1, 2001; 121(3): 532 - 541. [Abstract] [Full Text] [PDF]

				D. M. Meyer, L. E. Bennett, R. J. Novick, and J. D. Hosenpud Effect of Donor Age and Ischemic Time on Intermediate Survival and Morbidity After Lung Transplantation Chest, November 1, 2000; 118(5): 1255 - 1262. [Abstract] [Full Text] [PDF]

				I. Aleksic, M. M. Baryalei, B. Schorn, T. Busch, J. Strauch, A. Weyland, and H. Dalichau Heart Transplantation After Successful Donor Postpartum Pulmonary Embolectomy Chest, April 1, 1999; 115(4): 1202 - 1203. [Abstract] [Full Text] [PDF]

				W. E. Richenbacher Should Cardiac Transplantation Be Offered to Septuagenarians? Ann. Thorac. Surg., December 1, 1996; 62(6): 1578 - 1579. [Full Text]

				M. Pasic, M. Loebe, M. Hummel, O. Grauhan, J. Hofmeister, Y. Weng, and R. Hetzer Heart Transplantation: A Single-Center Experience Ann. Thorac. Surg., December 1, 1996; 62(6): 1685 - 1690. [Abstract] [Full Text]

				C. Blanche, J. M. Matloff, T. A. Denton, L. S. C. Czer, M. C. Fishbein, J. J. M. Takkenberg, and A. Trento Heart Transplantation in Patients 70 Years of Age and Older: Initial Experience Ann. Thorac. Surg., December 1, 1996; 62(6): 1731 - 1736. [Abstract] [Full Text]

				C. Blanche, J. J. M. Takkenberg, S. Nessim, M. Cohen, L. S. C. Czer, J. M. Matloff, and A. Trento Heart Transplantation in Patients 65 Years of Age and Older: A Comparative Analysis of 40 Patients Ann. Thorac. Surg., November 1, 1996; 62(5): 1442 - 1446. [Abstract] [Full Text]

				C. Blanche, C. Hwang, M. Valenza, R. M. Kass, L. S. C. Czer, W. J. Mandel, and A. Trento Wolff-Parkinson-White Syndrome in a Cardiac Allograft Ann. Thorac. Surg., March 1, 1995; 59(3): 744 - 746. [Abstract] [Full Text]